BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $412,000 | +34.6% | 5,030 | -21.7% | 0.28% | +56.6% |
| Q3 2016 | $306,000 | +7.7% | 6,425 | +2.4% | 0.18% | +7.1% |
| Q2 2016 | $284,000 | -15.0% | 6,275 | -22.8% | 0.17% | -22.4% |
| Q1 2016 | $334,000 | +5.7% | 8,125 | -1.8% | 0.22% | +1.9% |
| Q4 2015 | $316,000 | +14.1% | 8,275 | -1.8% | 0.22% | +11.4% |
| Q3 2015 | $277,000 | -53.0% | 8,425 | 0.0% | 0.19% | -48.1% |
| Q2 2015 | $589,000 | +7.1% | 8,425 | +5.0% | 0.37% | +11.0% |
| Q1 2015 | $550,000 | -11.7% | 8,025 | -5.6% | 0.34% | -10.7% |
| Q4 2014 | $623,000 | +8.5% | 8,500 | +6.2% | 0.38% | -1.1% |
| Q3 2014 | $574,000 | -5.4% | 8,000 | -4.8% | 0.38% | -4.8% |
| Q2 2014 | $607,000 | -7.3% | 8,400 | -5.6% | 0.40% | -11.9% |
| Q1 2014 | $655,000 | +1.9% | 8,900 | -3.8% | 0.45% | -1.3% |
| Q4 2013 | $643,000 | -11.4% | 9,250 | -16.3% | 0.46% | -16.7% |
| Q3 2013 | $726,000 | -14.5% | 11,050 | -9.8% | 0.55% | -12.1% |
| Q2 2013 | $849,000 | – | 12,250 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |